Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 22.30
-0.20 (-0.89%)
Apr 23, 2025, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 1.51 billion as of April 23, 2025. Its market cap has decreased by -8.85% in one year.
Market Cap
1.51B
Enterprise Value
2.19B
Revenue
171.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.30
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 1.51B, an increase of 4,823.95%. That is a compound annual growth rate of 25.75%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 90.33B |
| Sectra AB | 52.29B |
| Getinge AB | 49.98B |
| Camurus AB | 33.19B |
| Medicover AB | 31.53B |
| Vitrolife AB | 20.94B |
| Bonesupport Holding AB | 20.38B |
| AddLife AB | 18.68B |